ArticleTobacco control2022
Impact of the FDA flavour enforcement policy on flavoured electronic cigarette use behaviour changes.
Article in Tobacco control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Restricting choice of e-cigarette flavor and device type increases choices to use combusted cigarettes among adults who dual use both products: Results from a within-subjects randomized trial.Addictive behaviors · 2026Trial
- An experimental evaluation of the effects of banning the sale of flavored tobacco products on adolescents' and young adults' future nicotine vaping intentions.Addictive behaviors · 2023Trial
- "Cannabis Green Wave" versus "Nicotine Freeze": the regulatory paradox of cannabis liberalization and nicotine prohibition.Harm reduction journal · 2026Article
- Electronic cigarette use, related health outcomes and policy interventions in the USA: a call for research to fill evidence gaps.Tobacco control · 2026Review
- Spatiotemporal analysis of electronic cigarette discussion on Twitter/X using natural language processing.BMC public health · 2026Article
- The Intensity of Adolescent Substance Use Before and After the COVID-19 Pandemic.American journal of preventive medicine · 2026Article
- Spatiotemporal Analysis of Electronic Cigarette Perception on Twitter/X Using Natural Language Processing.Research square · 2026Article
- Digital footprints of the US e-cigarette market: correlations among retail sales data, social media activity and Google search trends.Tobacco control · 2025Article
- Rethinking E-Cigarette Flavor Policy: Can We Reduce Harm for Adults Without Inviting Youth Use?Journal of studies on alcohol and drugs · 2025Article
- Review
- US state implementation of policies restricting sales of flavoured E-cigarettes: a qualitative analysis.Tobacco control · 2025Article
- Guidance for Introducing the Tobacco-Free Generation Policy.The International journal of health planning and management · 2025Article
- Characteristics and ingredients of disposable 'Elfbar' e-cigarettes sold in the United States and the United Kingdom.Addiction (Abingdon, England) · 2025Article
- Article
- Microbiota-Influenced Toxicological Responses inmicroPublication biology · 2025Article
- Flavored electronic nicotine delivery system product use among adults in New York State post-statewide restriction implementation.Journal of public health policy · 2024Article
- Would banning menthol cigarettes, flavored cigars, and flavored e-cigarettes prompt users to seek illicit channels for obtaining them in the United States?Preventive medicine · 2024Article
- e-Cigarette Tobacco Flavors, Public Health, and Toxicity: Narrative Review.Online journal of public health informatics · 2024Review
- How might FDA fix this e-cigarette PMTA mess? Commentary on Glantz and Lempert and MeshnickTobacco control · 2024Article
- Flavored E-cigarette product aerosols induce transformation of human bronchial epithelial cells.Lung cancer (Amsterdam, Netherlands) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
introductionThis study aims to investigate electronic cigarette (e-cigarette) use behaviour changes after the implementation of the US Food and Drug Administration (FDA) restriction on the sale of all unauthorised flavoured cartridge-based e-cigarettes other than tobacco and menthol flavour on 6 February 2020, as well as factors associated with these changes.
methodsThrough Amazon's Mechanical Turk service, 3533 current adult flavoured e-cigarette users (who were not exclusive tobacco-flavoured or menthol-flavoured e-cigarette users) were recruited for an online survey from 8 July to 29 July 2021. Multiple logistic regression models were used to identify significant factors associated with quitting e-cigarette use, switching to other flavoured electronic nicotine delivery system (ENDS) products, switching to combustible tobacco products, switching to menthol-flavoured e-cigarettes and switching to tobacco-flavoured e-cigarettes.
resultsResulting from the FDA flavour enforcement policy, the top four e-cigarette use behaviour changes were: (1) switching to other flavoured ENDS products such as the tank system or disposable e-cigarettes (29.24%), (2) switching to menthol-flavoured pod systems (18.09%), (3) switching to combustible tobacco products (14.12%) and (4) switching to tobacco-flavoured pod systems (12.03%). There were 4.9% participants who indicated that they quit e-cigarette use. Overall, multiple factors, especially past 30-day use of certain flavours, were associated with different behaviour changes.
conclusionsThe implementation of the FDA flavour enforcement policy on cartridge-based e-cigarette was associated with significant e-cigarette behaviour changes, with multiple factors being associated with these changes. These results provide important information for future regulations of flavoured e-cigarette products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.